{
  "docId": "019dd923-622c-750b-8b9a-101b5bfde4b8",
  "docSlug": "a70fecd99534",
  "documentTitle": "Berkeley Lights (BLI)",
  "authorId": "58_Scorpion_Capital",
  "authorName": "Scorpion Capital",
  "documentKindSlug": "research-note",
  "documentKindLabel": "Research note",
  "sourceTypeSlug": "short_seller",
  "sourceTypeLabel": "Short seller",
  "presentationDate": "2021-09-15 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.2941177,
  "pageNumber": 127,
  "pageCount": 158,
  "prevPage": 126,
  "nextPage": 128,
  "slideType": "expose_contradiction",
  "function": "expose_contradiction",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": "The slide uses direct quotes from an executive to undermine the narrative of a $150MM deal.",
  "elementsJson": [
    "headline_text",
    "paragraph",
    "quote_block",
    "footnote"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-622c-750b-8b9a-101b5bfde4b8/127",
  "deckHref": "/decks/019dd923-622c-750b-8b9a-101b5bfde4b8",
  "deckJsonHref": "/decks/019dd923-622c-750b-8b9a-101b5bfde4b8.json",
  "deckAnchorHref": "/decks/019dd923-622c-750b-8b9a-101b5bfde4b8#slide-127",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "GINGKO BIOWORKS executive #1 was surprisingly cautious given the purportedly “$150MM deal” with BLI: “jury is still out” and too early to say whether the tool can compete against other screening technologies",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd953-2042-70a9-a1ae-14980f79d342",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.55,
        "w": 0.92,
        "x": 0.04,
        "y": 0.38
      },
      "kind": "list",
      "text": "Too early to say and “jury is still out” whether BLI can compete against other screening technologies... Not obvious what to use BLI’s instrument for; still trying to figure it out... Executive doesn’t “want to be unnecessarily pessimistic” but was nonetheless highly cautious about the partnership; not ordering a flurry of machines; can’t say whether it’ll actually ever be a $150MM deal",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "50830e30-1d57-48bd-8505-0e288e9f993b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.92,
        "x": 0.04,
        "y": 0.09
      },
      "kind": "paragraph",
      "text": "GINGKO BIOWORKS executive #1 was surprisingly cautious given the purportedly “$150MM deal” with BLI: “jury is still out” and too early to say whether the tool can compete against other screening technologies – a troubling statement given the deal was inked two years ago; not obvious what to use the instrument for and still trying to figure it out; executive doesn’t “want to be unnecessarily pessimistic” but was nonetheless highly circumspect about the partnership; not ordering a flurry of machines; can’t say whether it’ll actually ever be a $150MM deal.",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a4420ce2-ffe4-4231-983b-c2edab03a273",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "quote",
      "text": "It's still fairly early, and I can't say a ton...We're pushing in directions that have been not something that other folks have looked at because they don't look at microbes. To the extent that it can compete against other screening technologies, the jury is still out. It's sort of a bet that we've taken with Berkeley Lights to find out if that's the case. That's why I was a little bit qualified. — Gingko Bioworks Executive #1",
      "attrs": null,
      "subkind": null,
      "toolName": "Authority citation",
      "toolSlug": "authority-citation",
      "confidence": null,
      "componentId": "019dd953-2042-70a9-a1ae-184bfc1c64e4",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.25,
        "x": 0.04,
        "y": 0.96
      },
      "kind": "source-note",
      "text": "Source: Scorpion Capital consultation calls with experts",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "90e6a8b3-5eba-47d3-a95a-d86e01c96d78",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.18,
        "x": 0.04,
        "y": 0.05
      },
      "kind": "title",
      "text": "2Q) Gingko Bioworks",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "eb5053e7-93dd-439e-abb0-bb0da8438536",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "ceo-quote-contradiction",
      "slug": null,
      "matchId": "48378aaf-7683-4664-b30f-87a2497fe45f",
      "evidence": "Uses executive quotes to contradict the official $150MM deal narrative.",
      "confidence": 0.9
    }
  ],
  "arcBeats": [
    {
      "to": 150,
      "from": 42,
      "beatId": "172d6e2f-be3f-4802-92e5-e7e412ccdabe",
      "arcName": "Overcoming the Monster",
      "arcSlug": "overcoming-monster",
      "beatName": "Testimonials from Customers and Former Employees",
      "beatSlug": null,
      "evidence": "The document presents testimonials from customers and former employees, providing first-hand accounts of the challenges and limitations of Berkeley Lights' product.",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": null,
      "parentBeatSlug": null
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}